IL-23+ macrophages expanded anti-tumorigenic Th17 cells that had a distinct phenotype known as Th1-like Th17 cells and promoted tumor-specific immune responses by secreting IFN-γ, CXCL9 and CXCL10 [86,87]. Here, IL23A is linked to neoplasm.